Plasma HSP90α levels were significantly higher in patients with PAH as compared to CHD-only and control groups (11.36±5.67 ng/mL vs 6.24±1.99 ng/mL and 6.17±2.98 ng/mL, P < 0.05). This evidence concerns the gene HSP90AA1 and coronary artery disorder.